Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Payables: 2009-2024

Historic Payables for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $344.5 million.

  • UNITED THERAPEUTICS's Payables rose 28.61% to $468.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 24.70%. This contributed to the annual value of $344.5 million for FY2024, which is 15.60% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Payables of $344.5 million as of FY2024, which was up 15.60% from $298.0 million recorded in FY2023.
  • UNITED THERAPEUTICS's Payables' 5-year high stood at $344.5 million during FY2024, with a 5-year trough of $174.6 million in FY2021.
  • For the 3-year period, UNITED THERAPEUTICS's Payables averaged around $290.8 million, with its median value being $298.0 million (2023).
  • Per our database at Business Quant, UNITED THERAPEUTICS's Payables decreased by 6.63% in 2021 and then spiked by 31.67% in 2022.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Payables stood at $187.0 million in 2020, then fell by 6.63% to $174.6 million in 2021, then soared by 31.67% to $229.9 million in 2022, then grew by 29.62% to $298.0 million in 2023, then climbed by 15.60% to $344.5 million in 2024.